GlassScriptPhysician profile
Ankur Chhadia
NPI 1760698534
$30,450.59
in general payments reported to CMS, 2019-2025
20 companies · $8,940 in 2025
The $8,940 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,490 · 2020: $6,131 · 2021: $723 · 2022: $2,535 · 2023: $1,672 · 2024: $960 · 2025: $8,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,200 · Food and Beverage: $3,357 · Travel and Lodging: $2,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,200.00 |
| Food and Beverage | $3,357.07 |
| Travel and Lodging | $2,015.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $14,062.61 | 2019-2025 | Nanotack Flex, 1788, Spy-Phi System |
| Arthrex, INC. | $11,534.12 | 2019-2021 | |
| Horizon Therapeutics Plc | $3,656.26 | 2019 | |
| Medwest Associates | $288.21 | 2020-2022 | |
| Ermi LLC | $237.04 | 2019-2023 | |
| Bone Support INC. | $133.19 | 2025 | Ceramentbone Void Filler, Cerament G |
| Orthofix Medical, INC. | $115.81 | 2021-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $70.34 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $58.58 | 2024-2025 | |
| Vericel Corporation | $52.61 | 2019-2022 | |
| Depuy Synthes Sales INC. | $50.54 | 2022-2024 | Orthovisc, Monovisc |
| Kerecis Limited | $37.87 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Lightbody Medical Technologies INC | $35.71 | 2023 | |
| Djo, LLC | $31.48 | 2024 | Cmf |
| Heron Therapeutics, INC. | $25.47 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthosensor INC. | $16.87 | 2020 | |
| Collegium Pharmaceutical, INC. | $13.48 | 2019 | |
| Trice Medical, INC. | $11.44 | 2019 | |
| Integra Lifesciences Corporation | $10.96 | 2019 | |
| Sonex Health, INC. | $8.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Chhadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.